How much blood is needed?

Vox Sanguinis

Volumn 100, Issue 1, 2011, Pages 10-21

  Seifried, E ^a   Klueter, H ^b   Weidmann, C ^b   Staudenmaier, T ^c   Schrezenmeier, H ^c   Henschler, R ^a   Greinacher, A ^d   Mueller, M M ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Adequate use of blood components; Ageing of population; Blood donors; Consumption of blood products; Population demographics

Indexed keywords

BLOOD SUBSTITUTE;

AGE DISTRIBUTION; AGING; ANEMIA; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD TRANSFUSION; DEMOGRAPHY; DEVELOPED COUNTRY; EMBRYONIC STEM CELL; EUROPE; GERMANY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; RED CROSS; REVIEW; RISK FACTOR; SEX RATIO; THROMBOCYTE TRANSFUSION; UNITED STATES;

AGING; ANEMIA; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; DEVELOPED COUNTRIES; EUROPE; FEMALE; GERMANY; HEMATOLOGIC DISEASES; HUMANS; MALE; NEOPLASMS; PREOPERATIVE PERIOD; UNITED STATES;

EID: 78650388864     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01446.x     Document Type: Review

References (29)

1. World Health Organization: 10 facts on blood transfusion [document on the Internet]. WHO 2009 June 14 [accessed 2010 June 3 and September 27] from.
2. Mountford J, Olivier E, Turner M: Prospects for the manufacture of red cells for transfusion. Br J Haematol 2010; 149:22-34
3. Ali A, Auvinen MK, Rautonen J: The aging population poses a global challenge for blood services. Transfusion 2010; 50:584-588
4. Beguin C, Closon MC, Vandekerckhove P, et al. Concentration of transfusion resources on a few pathologies and a few patients: analysis of the comprehensive in-hospital patient database. Transfusion 2007; 47:217-227
5. Wells AW, Mounter PJ, Chapman CE, et al. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002; 325:803-806
6. Barr PJ, Donnelly M, Morris K, et al. The epidemiology of red cell transfusion. Vox Sang 2010; 99:239-250
7. Borkent-Raven BA, Janssen MP, van der Poel CL, et al. The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010; 99:54-64
8. Vamvakas EC, Taswell HF: Epidemiology of blood transfusion. Transfusion 1994; 34:464-470
9. Anderson SA, Menis M, O'Connell K, et al. Blood use in inpatient elderly population in the United States. Transfusion 2007; 47:582-592
10. Gombotz H, Rehak PH, Shander A, et al. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47:1468-1480
11. Wu WC, Schifftner TL, Henderson WC, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297:2481-2488
12. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65-years and older in the United States: evidence of a hight rate of unexplained anemia. Blood 2004; 104:2263-2268
13. Henseler O, Heiden M, Haschberger B, et al. Report on notifications pursuant to §21 German transfusion act for 2007. Transfus Med Hemother 2010; 37:29-47
14. German registry for stem cell transplantation (DRST): Yearly reports 2008 & 2009 [document on the Internet]. DRST 2010 [accessed 2010, July 19]; Available from.
15. Eisenmenger M, Poetzsch O, Sommer B: Bevoelkerung Deutschlands bis 2050-11. koordinierte Bevoelkerungsvorausberechnung [document on the Internet]. Statistisches Bundesamt, Wiesbaden 2006 [accessed 2009 Sept 9]; Available from.
16. Currie CJ, Patel TC, McEwan P, et al. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med 2004; 14:19-24
17. Maziarz RT: Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors? Curr Opin Hematol 2008; 15:127-133
18. Katalinic A, Peters E, Beske F, et al. Projection of morbidity 2030 and 2050: impact for the national health system and blood supply. Transfus Med Hemother 2010; 37:155-159
19. Zentrales Knochenmarkspender-Register Deutschland (ZKRD): Annual report 2004-2006 [document on the Internet]. ZKRD Ulm 2009 [accessed 2009 Sept 9]; from.
20. Zentrales Knochenmarkspender-Register Deutschland (ZKRD): Annual report 2007/08 [document on the Internet]. ZKRD Ulm 2010 [accessed 2010 May 10]; from.
21. Weissinger F, Sandmaier BM, Maloney DG, et al. Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood 2001; 98:3584-3588
22. Greinacher A, Fendrich K, Alpen U, et al. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 2007; 47:395-401
23. Riley W, Schwei M, McCullough J: The United States' potential blood donor pool: estimating the prevalence of donor-exclusion factors on the pool of potential donors. Transfusion 2007; 47:1180-1188
24. Eder AF, Hillyer CD, Dy BA, et al. Adverse reactions to allogeneic whole blood donation by 16 and 17-year-olds. JAMA 2008; 299:2279-2286
25. Ehling M, Pötzsch O: Demographic changes in Germany up to 2060 - consequences for blood donation. Transfus Med Hemother 2010;37:131-139
26. Bonig H, Chang KH, Geisen C, et al. Blood types of current embryonic stem cell lines are not conductive to culturing 'universal-donor' red blood cells. (letter). Transfusion 2010; 48:1039-1040
27. Greinacher A, Fendrich K, Hoffmann W: Demographic changes: the impact for safe blood supply. Transfus Med Hemother 2010; 37:141-148
28. Goette L, Stutzer A, Frey BM: Prosocial motivation and blood donations: a survey of the empirical literature. Transfus Med Hemother 2010; 37:149-154
29. Eurostat: Population of the European Union by age and sex. [document on the Internet]. Eurostat 2010 [accessed 2010, July 19]; from.